Fezolinetant for treating vasomotor symptoms associated with the menopause [ID5071]
In development
Reference number: GID-TA11058
Expected publication date: TBC
Following the release of the Draft Guidance for this appraisal, the company requested additional time to respond. NICE has agreed to an extension and as a result the date for the second committee meeting is to be confirmed.